1,234 results on '"Smedira, Nicholas"'
Search Results
2. Are there etiology-specific risk factors for adverse outcomes in patients on Impella 5.5 support?
3. Multifocal disease progression and subsequent intervention in patients with actin alpha-2 variants: A single-center experience
4. Does Everyone Need High Technology Intervention Before They Die?
5. Abstract 18270: Interagency Registry for Mechanically Assisted Circulatory Support Profile is Associated With Outcomes in Patients With an Impella 5.5 Ventricular Assist Device
6. Abstract 18247: Society for Cardiovascular Angiography and Intervention Shock Staging is Associated With Outcomes in Patients With an Impella 5.5 Temporary Left Ventricular Assist Device
7. Abstract 17216: Limited Concordance of Core Lab Left Ventricular Ejection Fraction With Automated Assessments: A Sub-Study From VALOR-HCM
8. Invasive therapies for symptomatic obstructive hypertrophic cardiomyopathy
9. Patient reported outcomes in obstructive hypertrophic cardiomyopathy undergoing myectomy: Results from SPIRIT-HCM study
10. Public reporting for coronary artery bypass graft surgery: The quest for the optimal scorecard
11. Radical Pericardiectomy and Use of Cardiopulmonary Bypass for Constrictive Pericarditis
12. Prevalence of amyloid deposition in patients undergoing surgical myectomy for presumed hypertrophic cardiomyopathy OB7 (#532)
13. Left Ventricular Outflow Tract Obstruction in Cardiac Amyloidosis
14. Unmasking Severe Systolic Anterior Motion With Left Ventricular Outflow Tract Obstruction Following Mitral Valve Repair
15. Mitral Leaflet Shortening: Less About Technique, More About Collaborative Teamwork.
16. Redefining “low risk”: Outcomes of surgical aortic valve replacement in low-risk patients in the transcatheter aortic valve replacement era
17. Increasing surgeon experience and cumulative institutional experience drive decreasing hospital mortality after reoperative cardiac surgery
18. Modern practice and outcomes of reoperative cardiac surgery
19. Similar long-term survival after isolated bioprosthetic versus mechanical aortic valve replacement: A propensity-matched analysis
20. Mitral Regurgitation in Obstructive Hypertrophic Cardiomyopathy
21. Extended Septal Myectomy in Hipertrophic Obstructive Cardiomyopathy
22. Miectomia septal ampliada en la miocardiopatía hipertrófica obstructiva
23. Risks and Outcomes of Reoperative Cardiac Surgery in Patients With Patent Bilateral Internal Thoracic Artery Grafts
24. Incremental Value of Global Longitudinal Strain to Michigan Risk Score and Pulmonary Artery Pulsatility Index in Predicting Right Ventricular Failure Following Left Ventricular Assist Devices
25. Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy
26. Myosin Inhibition and Left Ventricular Diastolic Function in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Insights From the VALOR-HCM Study
27. Abstract 12598: Effect of Mavacamten on Systolic Anterior Motion of the Mitral Valve and Mitral Regurgitation in Patients With Obstructive Hypertrophic Cardiomyopathy: Insights From the VALOR-HCM Study
28. Abstract 12577: Effect of Mavacamten on Diastolic Function in Patients With Obstructive Hypertrophic Cardiomyopathy: Insights From the VALOR-HCM Study
29. Abstract 11324: Association of Patient Reported Outcomes With NYHA Class and Functional Capacity in Symptomatic Obstructive Hypertrophic Cardiomyopathy: An Analysis of Spirit-HCM Study
30. Outcomes after resection of primary cardiac sarcoma
31. Study design and rationale of VALOR-HCM: evaluation of mavacamten in adults with symptomatic obstructive hypertrophic cardiomyopathy who are eligible for septal reduction therapy
32. Multifocal Disease Progression and Subsequent Intervention in Patients with Actin Alpha-2 Variants; A Single Center Experience
33. What Determines Outcomes in Multivalve Reoperations? Effect of Patient and Surgical Complexity
34. Characteristics and Longer-Term Outcomes of Contemporary Patients
35. Predicting hypertension control using machine learning.
36. Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction
37. Mitral Valve Pathology in Hypertrophic Cardiomyopathy
38. Surgical management of left ventricular outflow tract obstruction in a specialized hypertrophic obstructive cardiomyopathy center
39. Advances in managing the noninfected open chest after cardiac surgery: Negative-pressure wound therapy
40. Extracorporeal Membrane Oxygenation in Pulmonary Endarterectomy Patients
41. Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Preserved Systolic Function
42. Continuously Updated Estimation of Heart Transplant Waitlist Mortality
43. Cardiac Surgical Procedures in Patients with Cirrhosis
44. Abstract 15426: Comparison of Multimodality Imaging in Mitral Leaflet Lengths in Patients Undergoing Surgical Myectomy: A Prospective Study in Hypertrophic Obstructive Cardiomyopathy Patients
45. Abstract 13038: Utility of Left Atrial Strain Mechanics and Stiffness in Patients With Hypertrophic Cardiomyopathy
46. Dose-Blinded Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Outcomes Through 32 Weeks
47. IMPROVEMENT IN MULTI-DOMAIN PATIENT-REPORTED OUTCOME SCORES WITH MAVACAMTEN TREATMENT IN OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY: INSIGHTS FROM THE VALOR-HCM STUDY
48. TEMPORAL CHANGES IN VARIOUS ECHOCARDIOGRAPHIC PARAMETERS FOLLOWING SURGICAL MYECTOMY IN SEVERELY SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY: RESULTS FROM THE PROSPECTIVE SPIRIT-HCM STUDY
49. ACCELERATED MITRAL ANNULAR CALCIFICATION (MAC) IN PATIENTS WITH FABRY'S DISEASE (FD)
50. Redefining “low risk”: Outcomes of surgical aortic valve replacement in low-risk patients in the transcatheter aortic valve replacement era
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.